Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Vaccines

  Free Subscription


31.08.2026

1 Arch Virol
5 BMJ
2 J Infect Dis
1 J Virol
1 Lancet
1 Nat Immunol
1 Nat Med
1 Pediatr Infect Dis J
4 PLoS One
1 Proc Natl Acad Sci U S A
12 Vaccine


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Arch Virol

  1. GROSS S, Dalphin L, Dor F, Ramanah R, et al
    Frequent detection of high-risk HPV types other than HPV 16/18 in a cohort of French women who claimed to have been vaccinated.
    Arch Virol. 2026;171:262.
    PubMed         Abstract available


    BMJ

  2. WASSWA H
    Ebola: WHO declares Uganda free of virus, but doctors express reservations about new vaccine trial.
    BMJ. 2026;394:e100708.
    PubMed        

  3. LANG K
    What are the real risks of covid vaccines and miscarriage?
    BMJ. 2026;394:e100682.
    PubMed        

  4. IACOBUCCI G
    Shingles vaccine is linked to lower risk of heart disease and stroke, study suggests.
    BMJ. 2026;394:e100711.
    PubMed        

  5. BARANIUK C
    Dolly Parton's major contributions to vaccines and public health.
    BMJ. 2026;394:e100694.
    PubMed        

  6. LIANG L
    US kindergarten vaccinations drop to new low.
    BMJ. 2026;394:e100647.
    PubMed        


    J Infect Dis

  7. WATTIAU P, Omar SV, Joseph L, Demoitie MA, et al
    Genetic characterization of M. tuberculosis isolates from participants in a Phase 2b randomized trial evaluating the M72/AS01E tuberculosis candidate vaccine.
    J Infect Dis. 2026 Aug 28:jiag428. doi: 10.1093.
    PubMed         Abstract available

  8. KHAYARGOLI P, Grace D, Cox J, de Pokomandy A, et al
    HPV vaccine effectiveness against prevalent HPV by age, years sexually active before vaccination, and HIV status in gay, bisexual, and other men who have sex with men, 2019-2021.
    J Infect Dis. 2026 Aug 26:jiag426. doi: 10.1093.
    PubMed         Abstract available


    J Virol

  9. KUMAR S, Lai L, Ellis ML, Patel A, et al
    Immunological imprinting shapes the cross-reactive antibody responses to the KP.2 and LP.8.1 vaccine doses.
    J Virol. 2026 Aug 26:e0074926. doi: 10.1128/jvi.00749.
    PubMed         Abstract available


    Lancet

  10. HALBROOK M, Merritt S, Hoff NA, Mukadi P, et al
    Bundibugyo virus glycoprotein seroreactivity following recombinant vesicular stomatitis virus-Zaire Ebola virus glycoprotein vaccination in outbreak-affected populations of the Democratic Republic of the Congo: a longitudinal cohort study.
    Lancet. 2026 Aug 25:S0140-6736(26)01608-9. doi: 10.1016/S0140-6736(26)01608.
    PubMed         Abstract available


    Nat Immunol

  11. JOHNSTON TS, Li SH, Painter MM, Swaminathan D, et al
    Potent type-specific de novo antibodies complement broadly reactive imprinted antibodies in immune responses to SARS-CoV-2 variants.
    Nat Immunol. 2026;27:1874-1886.
    PubMed         Abstract available


    Nat Med

  12. CORSI-ZUELLI F, Li F, Upthegrove R, Todd JA, et al
    Recombinant shingles vaccination and the risk of cardiovascular events.
    Nat Med. 2026 Aug 26. doi: 10.1038/s41591-026-04606.
    PubMed         Abstract available


    Pediatr Infect Dis J

  13. THURAU NM, Tometten I, Lubke N, Michels BE, et al
    Immunologic Response and Clinical Course After Off-label Nonavalent HPV Vaccination in Juvenile-onset Recurrent Respiratory Papillomatosis Patients.
    Pediatr Infect Dis J. 2026 Aug 26. doi: 10.1097/INF.0000000000005381.
    PubMed         Abstract available


    PLoS One

  14. ARTEMCHUK O, Chakhunashvili G, Finci I, Rojas M, et al
    Factors associated with influenza vaccine uptake among healthcare workers in Georgia, 2021-2024.
    PLoS One. 2026;21:e0356495.
    PubMed         Abstract available

  15. LIAQAT A, Dastgir K, Sajjad M, Rehman HM, et al
    In silico framework for designing and validating a multi-stage subunit vaccine against Tuberculosis using reverse vaccinology approach.
    PLoS One. 2026;21:e0356788.
    PubMed         Abstract available

  16. EKHOLUENETALE M
    Decomposing socioeconomic inequalities in COVID-19 vaccination uptake among Nigerian women of reproductive age: A further analysis of population-based data.
    PLoS One. 2026;21:e0357171.
    PubMed         Abstract available

  17. BANDOH DA, Dzodzomenyo M, Kenu E, Dennis FE, et al
    Enteric Pathogens in children under five with diarrhoea in a rotavirus vaccinated population in Coastal Ghana, 2023.
    PLoS One. 2026;21:e0356904.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  18. MONTGOMERIE I, McKenzie RE, Palmer OR, Mason NC, et al
    Engineering antigenic breadth against SARS-CoV-2 by pairing divergent RBDs within a single mRNA immunogen.
    Proc Natl Acad Sci U S A. 2026;123:e2602574123.
    PubMed         Abstract available


    Vaccine

  19. HARIYANTO TI
    Measles resurgence in Indonesia: the intersection of immunity gaps, subnational heterogeneity, and vaccine confidence.
    Vaccine. 2026;91:129085.
    PubMed        

  20. NITTA T, Kashiyama T, Matsumoto Y, Toyoda T, et al
    Residual DNA in COVID-19 mRNA vaccines: Regulatory context and misinformation.
    Vaccine. 2026;91:129080.
    PubMed        

  21. GUTIERREZ AM, Do MH, Motta M
    Psychometric validity evidence for a measure of trust in U.S. public health actors for vaccine information.
    Vaccine. 2026;91:129026.
    PubMed         Abstract available

  22. GENSOROWSKY D, Surmann B, Meyer AC, Poshtiban A, et al
    Corrigendum to "Outpatient care intensity and influenza vaccination: evidence from Germany" [Vaccine 70 (2026) 128038].
    Vaccine. 2026;90:129062.
    PubMed        

  23. NUNES JPDS, Daher IP, Pires ADS, Yamamoto MM, et al
    Synergistic effect of AddaS03 and poly I:C adjuvants on antibody titers and Th1-biased T cell responses following RBD vaccination in BALB/c mice.
    Vaccine. 2026;91:129073.
    PubMed         Abstract available

  24. PORTILHO AI, Andreata-Santos R, Duarte-Barbosa M, Chaves APC, et al
    Functional neutralizing and bactericidal antibody responses induced by dual-target immunization with SARS-CoV-2 RBD and Neisseria meningitidis antigens in mice.
    Vaccine. 2026;90:129011.
    PubMed         Abstract available

  25. ISLAM MA, Zehra SM, Kazi Z, Ather S, et al
    A multi-center, open-labelled, randomized controlled extended phase III non-inferiority clinical trial to evaluate the immunogenicity and tolerability of poliomyelitis vaccine (Vero cells), inactivated, Sabin strains administered with or without routi
    Vaccine. 2026;91:129095.
    PubMed         Abstract available

  26. LI Q, Bai G
    Central nervous system safety risks and evaluation strategies for mucosal vaccines: A review.
    Vaccine. 2026;91:129084.
    PubMed         Abstract available

  27. MACKENZIE LJ, Bousie JA, Newman P, Preston P, et al
    Muscle size matters: making paediatric vaccination safe for all - a pilot study.
    Vaccine. 2026;91:129076.
    PubMed         Abstract available

  28. SCHRARSTZHAUPT IN, Diaz-Quijano FA
    Effectiveness of COVID-19 vaccination schedules against severe COVID-19 in children aged 6 months to 4 years in Brazil: A population-based cohort study (2023-2024).
    Vaccine. 2026;91:129096.
    PubMed         Abstract available

  29. BOTT L, Liu J, Challenger A, Powell E, et al
    Myth-busting influenza and fear of adverse reactions in healthcare workers: two experimental studies on vaccination intentions.
    Vaccine. 2026;91:129086.
    PubMed         Abstract available

  30. ANAND A, Jepkosgei D, Mwachari C, Jalang'o R, et al
    Immunogenicity of type 2 novel oral poliovirus vaccine administered in outbreak response, Kenya 2023: an observational cohort study.
    Vaccine. 2026;91:128969.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum